Natural Soya Lecithin 300 mg

product on market Softgel Capsule Solgar 🟢 Safety: 100/100
Brand: Solgar
🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →
📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

6 Softgel(s) Serving Size
41 Servings
Fat/Fatty Acid Product Type
25% Evidence Coverage

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1.5 Gram(s) (2% DV)
35 mg (4% DV)
✅ Within RDA (0.1× RDA of 700 mg) 📚 12 studies (Tier A: 0, B: 3)
RDA 700mg This product: 35mg UL 4000mg
Lecithin
1800 mg

Other Ingredients

Gelatin Glycerin Water

Label Claims — Verification

❓ All Other
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Adult (18 - 50 Years) Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use: As a dietary supplement for adults, take six (6) softgels daily, preferably at mealtime, or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Do not use if outer bottle seal is missing, torn or damaged in any way.

If you are pregnant, nursing, taking any medication or have a medical condition, please consult your healthcare practitioner before taking any dietary supplement.

Keep out of reach of children.

🧪 Formulation Notes

Solgar's Soya Lecithin Softgels are unbleached, free of corn, yeast, whet and dairy products and are formulated without the use of preservative, artificial flavors or colors.

Sugar, salt and starch free

Formulated for adults.

Natural Soya Lecithin 300 mg per softgel

Additional Information

To assure freshness and potency, store at room temperature 15 degrees-30 degrees C (59 degrees-86 degrees F). Store away from heat, light and moisture.

Solgar since 1947

Product Details

UPC / SKU 0 33984 01521 0
DSLD Entry Date 2020-02-26
Product Type Fat/Fatty Acid
Form Softgel Capsule
Brand Solgar
DSLD ID 214602
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
PubMed DOI Cochrane
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
PubMed DOI Cochrane
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
PubMed DOI
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
PubMed DOI Cochrane
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
PubMed DOI
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
PubMed DOI
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
PubMed DOI
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
PubMed DOI
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
PubMed DOI
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
PubMed DOI
View all evidence for Phosphorus →

Compare Similar Products

Phosphatidyl Serine Complex 500 mg Viva Vitamins 100
Natural Soya Lecithin 300 mg Solgar 100
CLA 2000 2000 mg Zazzee Naturals 100
CLA 3600 Zazzee Naturals 100
Phosphatidyl Serine Complex 500 mg Martin Avenue Pharmacy 100
View all Phosphorus products →
Phosphorus research & evidence Best Phosphorus rankings All Phosphorus products More from Solgar View on NIH DSLD →